More on CRSP

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+100.0% Growth)
- Ratings (5.6 Score)
- Holders

Upcoming Events

- Earnings (8/4/26 *Est.)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

CRISPR Therapeutics (NQ:CRSP)
Delayed: 56.50 -0.83 (1.45%)
Prev. Close $57.33  
Open$55.11 
52 Wk High$18.88 
52 Wk Low$13.75 
Day High$57.04 
Day Low$54.80 
P/E N/A  
EPS$0.00 
Volume1,167,716 

Friends, Peers and Foes (?): NTLA, BEAM, EDIT, DTIL, MGX (more...)

Feb 20, 2026 05:37 PM Form 4 CRISPR Therapeutics AG For: Feb 18 Filed by: Kulkarni Samarth
Feb 20, 2026 05:36 PM Form 4 CRISPR Therapeutics AG For: Feb 18 Filed by: KASINGER JAMES R.
Feb 17, 2026 12:06 PM Form SCHEDULE 13G/A CRISPR Therapeutics AG Filed by: ORBIS INVESTMENT MANAGEMENT LTD
Feb 17, 2026 08:36 AM CRISPR Therapeutics (CRSP) PT Raised to $33 at Morgan Stanley
Feb 13, 2026 09:54 AM CRISPR Therapeutics (CRSP) PT Raised to $45 at TD Cowen
Feb 13, 2026 09:19 AM CRISPR Therapeutics (CRSP) PT Raised to $74 at Evercore ISI
Feb 13, 2026 08:50 AM CRISPR Therapeutics (CRSP) PT Lowered to $6 at Baird
Feb 13, 2026 08:06 AM CRISPR Therapeutics (CRSP) PT Raised to $82 at Needham
Feb 13, 2026 06:25 AM CRISPR Therapeutics (CRSP) PT Lowered to $86 at BofA Securities
Feb 12, 2026 05:17 PM CRISPR Therapeutics (CRSP) Misses Q4 EPS by 20c
View All Articles

Entities mentioned with CRSP

View All Entities